Treatment of Tourette Syndrome in Children with N-Acetylcysteine (NAC)

Purpose

To determine whether N-Acetylcysteine (NAC) is effective in treating children with Tourette syndrome (TS).

Criteria for Participation

• Children 8-17 with chronic Tourette syndrome.

Research Components

Subjects receive active N-Acetylcysteine (a natural supplement) or a placebo and can remain on current medications. Treatment is free and participants are paid up to $150 for participation in the study.

Contacts

Please contact us for further information if you are interested in participating in this new study at the Yale Child Study Center.

Jilian Mulqueen 
(203) 737-4809
jilian.mulqueen@yale.edu